Video
Question 1
| What are some of the particular challenges and opportunities that Access to Medicines is seeing right now in supply chain and building supply chain capacity? What steps need to be taken right now under COVID-19 to address them and how can we be planning for post COVID-19? |
Question 2
| Today we’ve seen innovative solutions for access to medicines from a financing and platform perspective. Do you see these as potential solutions, are there other challenges that need to be addressed and how can we scale these further? |
Closing Statement
For the latest Access to Medicine Index, including best practices, please visit Access to Medicine Index.